Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Romagnolo, A. Hirota, C. Tanaka, C. Fu (Sao Paulo, SP, Brazil). Ventilation-associated pneumonia: probability of occurence as a function of time. Eur Respir J 2007; 30: Suppl. 51, 2410

Member's Comments

No comment yet.

Related content which might interest you: Oxy-Met score: a new physiological index to predict mortality in community-acquired pneumonia Source: International Congress 2017 – Update on community acquired pneumonia Year: 2017 COPD: what is the frequency and impact of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 The main risk factors of the community-acquired pneumonia delayed course Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005 Management-based risk prediction in community-acquired pneumonia by scores and biomarkers Source: Eur Respir J 2013; 41: 974-984 Year: 2013 Defining community-acquired pneumonia severity on presentation to hospital: a derivation study Source: Eur Respir J 2004; 24: Suppl. 48, 186s Year: 2004 3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors Source: Eur Respir J 2016; 47:1572-1574 Year: 2016 The post-tuberculosis lung changes as risk factor of the community-acquired pneumonia delayed course Source: Eur Respir J 2006; 28: Suppl. 50, 351s Year: 2006 Mortality in patients with ventilator-associated pneumonia (VAP) and severe sepsis is determined by the number of organ failures Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Treatment failure of community-acquired pneumonia: risk factors and consequences Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections Year: 2012 Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia Source: Eur Respir J 2007; 30: 517-524 Year: 2007 Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia Source: Annual Congress 2007 - Infections year in review Year: 2007 Initial management of pneumonia and sepsis: factors associated with improved outcome Source: Eur Respir J 2012; 39: 156-162 Year: 2012 Initial management of pneumonia and sepsis: factors associated with improved outcome Source: Eur Respir J 2011; 39: 156-162 Year: 2012 Prevention is better than cure: time to change the focus of community-acquired pneumonia management Source: Eur Respir J 2015; 45: 1524-1525 Year: 2015 I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas! Year: 2009 Lung vessel thrombosis like the reason of mortality at severe community-acquired pneumonia (CAP) of viral and bacterial etiology - autopsy data Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Defining stability in pneumonia and the non-responding pneumonia Source: Annual Congress 2005 - Outcome in severe pneumonia Year: 2005 Initial risk class and length of hospital stay in community-acquired pneumonia Source: Eur Respir J 2001; 18: 151-156 Year: 2001 Inflammatory responses predict long-term mortality risk in community-acquired pneumonia Source: Eur Respir J 2011; 37: 1439-1446 Year: 2011 Validation of a predictive rule for the management of community-acquired pneumonia Source: Eur Respir J 2006; 27: 151-157 Year: 2006